Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-23 · accession 0001209191-21-066783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-24 | 2021-11-23 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.58 | -52.6K | 618.5K | -8% | -$609.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-11-23 | S | D | 52,644 | $11.58 | 618,545 | D | — | — |